Minos Biosciences incorporated
First investment from PSL & incubation at PC-up
Our approach
Minos Biosciences BRIDGES MOLECULAR and CELL BIOLOGY in a manner never achieved before, allowing scientists to uncover the full picture of cell diversity and dynamics.
What You See Is What You Seq
SINGLE-CELL REVOLUTION
Single-cell analysis has proven to be decisive in tackling cell diversity, and it has become in recent years an irreplaceable tool in all fields of biological and medical research.
Current single-cell technologies however, only provide a narrow-angled, fragmented view – whereas multi-modal cell analysis is the key to unlocking biological complexity in all its dimensions.
MINOS SOLUTION
Connecting, at cell resolution, MULTI-OMICS ANALYSIS with DYNAMIC FUNCTIONAL ASSAYS, Minos’ cell analysis platform provides an in-depth and comprehensive understanding of the molecular mechanisms underlying cell function and dynamics, in complex biological systems such as tumours and their micro-environment.
Our unique, CAGE-tag™ microfluidic technology combines image-based, dynamic functional monitoring and sequence-based molecular profiling of individual or multiple cells at high throughput, to generate data of unprecedented depth and value.
Minos will deliver a range of high-impact assays, easily run on our bench top instrument, and will provide streamlined and user-friendly data analysis via an integrated or cloud-based AI-powered software.
MINOS IMPACT
Minos provides a novel paradigm in cell analysis that will open new frontiers in life sciences research, drug discovery & development and precision medicine. Minos solution generates novel and unique datasets primed for AI-driven analysis with the capacity to majorly impact our understanding and management of severe pathologies, such as:
- Cancer: linking genetic & non-genetic factors to tumour cell plasticity and/or immune interaction will be decisive in discovering novel targets, tackling drug resistance, and designing effective and more personalised therapeutic strategies.
- Autoimmune disorders: unravelling the complex role of immune cells at the multi-omic and phenotypic levels will result in the development of better treatments.
- Infectious disease: correlating host-pathogen interaction to genetic and epigenetic variations will allow elucidating infection and proliferation mechanisms to improve therapy and prevention.
Our History
Minos Biosciences was born in 2020, out of the PhD works and entrepreneurial spirit of Hubert Geisler and Gaël Blivet-Bailly (who are at the origin of the technology), meeting with the in-depth scientific and clinical expertise of its co-founders, such as Prof Andrew Griffiths (co-inventor of phage display –Nobel Prize 2018-, co-founder of Raindance, HiFiBiO…).
Meet Our Team
Anne-Sophie Carrese
Partner at Elaia Partners
17 years in deeptech financing & investment
Luc Selig, PhD
Independent Board member
CEO of CYTOO
20+ years experience in strategic marketing and business development
Pierre Le Ber, PhD
Chief Executive Officer
Ex-director of France Génomique
30 years pharma & biotech experience
Andrew Griffiths, PhD
Professor at ESPCI Paris – PSL
World renowned single-cell expert & highly successful entrepreneur
Claude Hennion, PhD
Independent Board Member
CEO & Founder OncoDiag
Serial entrepreneur for 25+ years in the biotech & diagnostics field
Pierre Le Ber, PhD
Chief Executive Officer
Ex-director of France Génomique
30 years pharma & biotech experience
Hubert Geisler, PhD
Product Director
Co-founder & microfluidic inventor
Gaël Blivet-Bailly, PhD
Scientific Director
Co-founder & molecular biology inventor
Mathieu Bahin
Head of Data Science
Imaging x Sequencing
Tenured CNRS bioinformatics engineer
Aurélien de Reyniès, PhD
University professor & hospital practitioner (PUPH) at Paris Cité University
Jérôme Cros, MD-PhD
Professor of pathology & hospital practitioner (PUPH) at Greater Paris University Hospitals
Andrew Griffiths, PhD
Professor at ESPCI Paris – PSL
World renowned single-cell expert & highly successful entrepreneur
Yannick Rondelez, PhD
Molecular systems, Director of Research CNRS at ESPCI Paris – PSL
Patrick Tabeling, PhD
Microfluidics, Professor at ESPCI Paris – PSL
Our Partners
Awards & Achievements
Explore our open positions on Linkedin ➞